Making Sense of Antisense lncRNAs in Hepatocellular Carcinoma
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms24108886 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Nicola Mosca und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Environmental, Biological and Pharmaceutical Sciences and Technologies, University of Campania "Luigi Vanvitelli", 81100 Caserta, Italy. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, RNA, Long Noncoding, Liver Neoplasms. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 201 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Campania "Luigi Vanvitelli", University of Campania “L. Vanvitelli”.
Abstract (Originalsprache)
Transcriptome complexity is emerging as an unprecedented and fascinating domain, especially by high-throughput sequencing technologies that have unveiled a plethora of new non-coding RNA biotypes. This review covers antisense long non-coding RNAs, i.e., lncRNAs transcribed from the opposite strand of other known genes, and their role in hepatocellular carcinoma (HCC). Several sense–antisense transcript pairs have been recently annotated, especially from mammalian genomes, and an understanding of their evolutionary sense and functional role for human health and diseases is only beginning. Antisense lncRNAs dysregulation is significantly involved in hepatocarcinogenesis, where they can act as oncogenes or oncosuppressors, thus playing a key role in tumor onset, progression, and chemoradiotherapy response, as deduced from many studies discussed here. Mechanistically, antisense lncRNAs regulate gene expression by exploiting various molecular mechanisms shared with other ncRNA molecules, and exploit special mechanisms on their corresponding sense gene due to sequence complementarity, thus exerting epigenetic, transcriptional, post-transcriptional, and translational controls. The next challenges will be piecing together the complex RNA regulatory networks driven by antisense lncRNAs and, ultimately, assigning them a function in physiological and pathological contexts, in addition to defining prospective novel therapeutic targets and innovative diagnostic tools.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Environmental, Biological and Pharmaceutical Sciences and Technologies, University of Campania "Luigi Vanvitelli", 81100 Caserta, Italy.
ORCID-Profile: Nicola Mosca, Aniello Russo, Nicoletta Potenza
Förderung
- University of Campania "Luigi Vanvitelli"
- University of Campania “L. Vanvitelli”
Zitieren
APA
Mosca, N., Russo, A., & Potenza, N. (2023). Making Sense of Antisense lncRNAs in Hepatocellular Carcinoma. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24108886
Vancouver
Mosca N, Russo A, Potenza N. Making Sense of Antisense lncRNAs in Hepatocellular Carcinoma. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24108886
BibTeX
@article{Mosca2023,
author = {Mosca, Nicola and Russo, Aniello and Potenza, Nicoletta},
title = {Making Sense of Antisense lncRNAs in Hepatocellular Carcinoma},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms24108886}
}
EUVIMED